| Colloidal carriers and blood–brain barrier (BBB) translocation: a way to deliver drugs to the brain? E Garcia-Garcia, K Andrieux, S Gil, P Couvreur International journal of pharmaceutics 298 (2), 274-292, 2005 | 492 | 2005 |
| Development and brain delivery of chitosan− PEG nanoparticles functionalized with the monoclonal antibody OX26 Y Aktaş, M Yemisci, K Andrieux, RN Gürsoy, MJ Alonso, ... Bioconjugate chemistry 16 (6), 1503-1511, 2005 | 397 | 2005 |
| Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues D Brambilla, B Le Droumaguet, J Nicolas, SH Hashemi, LP Wu, ... Nanomedicine: Nanotechnology, Biology and Medicine 7 (5), 521-540, 2011 | 369 | 2011 |
| Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury A Gaudin, M Yemisci, H Eroglu, S Lepetre-Mouelhi, OF Turkoglu, ... Nature nanotechnology 9 (12), 1054-1062, 2014 | 264 | 2014 |
| A nanomedicine transports a peptide caspase-3 inhibitor across the blood–brain barrier and provides neuroprotection H Karatas, Y Aktas, Y Gursoy-Ozdemir, E Bodur, M Yemisci, S Caban, ... Journal of Neuroscience 29 (44), 13761-13769, 2009 | 251 | 2009 |
| Translocation of Poly(ethylene glycol-co-hexadecyl)cyanoacrylate Nanoparticles into Rat Brain Endothelial Cells: Role of Apolipoproteins in Receptor-Mediated … HR Kim, K Andrieux, S Gil, M Taverna, H Chacun, D Desmaële, F Taran, ... Biomacromolecules 8 (3), 793-799, 2007 | 225 | 2007 |
| Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells HR Kim, S Gil, K Andrieux, V Nicolas, M Appel, H Chacun, D Desmaele, ... Cellular and molecular life sciences 64, 356-364, 2007 | 217 | 2007 |
| PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer’s disease D Brambilla, R Verpillot, B Le Droumaguet, J Nicolas, M Taverna, J Kona, ... ACS nano 6 (7), 5897-5908, 2012 | 204 | 2012 |
| Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system HR Kim, K Andrieux, C Delomenie, H Chacun, M Appel, D Desmaële, ... Electrophoresis 28 (13), 2252-2261, 2007 | 191 | 2007 |
| Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis Y de Kozak, K Andrieux, H Villarroya, C Klein, B Thillaye‐Goldenberg, ... European journal of immunology 34 (12), 3702-3712, 2004 | 180 | 2004 |
| Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor Y Aktaş, K Andrieux, MJ Alonso, P Calvo, RN Gürsoy, P Couvreur, ... International journal of pharmaceutics 298 (2), 378-383, 2005 | 176 | 2005 |
| Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer’s disease B Le Droumaguet, J Nicolas, D Brambilla, S Mura, A Maksimenko, ... ACS nano 6 (7), 5866-5879, 2012 | 170 | 2012 |
| Systemically administered brain-targeted nanoparticles transport peptides across the blood—brain barrier and provide neuroprotection M Yemisci, S Caban, Y Gursoy-Ozdemir, S Lule, R Novoa-Carballal, ... Journal of Cerebral Blood Flow & Metabolism 35 (3), 469-475, 2015 | 142 | 2015 |
| A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles E Garcia-Garcia, S Gil, K Andrieux, D Desmaële, V Nicolas, F Taran, ... Cellular and molecular life sciences 62, 1400-1408, 2005 | 141 | 2005 |
| Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model D Carradori, C Balducci, F Re, D Brambilla, B Le Droumaguet, O Flores, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (2), 609-618, 2018 | 132 | 2018 |
| Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood–brain barrier K Andrieux, P Couvreur Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1 (5 …, 2009 | 124 | 2009 |
| Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases P Couvreur, R Gref, K Andrieux, C Malvy Progress in solid state chemistry 34 (2-4), 231-235, 2006 | 122 | 2006 |
| A methodology to study intracellular distribution of nanoparticles in brain endothelial cells E Garcia-Garcia, K Andrieux, S Gil, HR Kim, T Le Doan, D Desmaële, ... International journal of pharmaceutics 298 (2), 310-314, 2005 | 90 | 2005 |
| Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism … K Andrieux, L Forte, S Lesieur, M Paternostre, M Ollivon, ... European Journal of Pharmaceutics and Biopharmaceutics 71 (2), 346-355, 2009 | 87 | 2009 |
| DSC and X-ray diffraction coupling: specifications and applications G Keller, F Lavigne, L Forte, K Andrieux, M Dahim, C Loisel, M Ollivon, ... Journal of thermal analysis and calorimetry 51, 783-791, 1998 | 83 | 1998 |
